Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Palm

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Journal of Clinical and Translational Science|January 17, 2024
The Trial Innovation Network Liaison Team: building a national clinical and translational community of practiceMarisha E Palm, Dixie D Thompson, Terri Edwards, et al.
Science Translational Medicine|December 10, 2020
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humansHaley L Dugan, Jenna J Guthmiller, Philip Arevalo, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Cell|April 7, 2018
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive AntibodiesYao-Qing Chen, Teddy John Wohlbold, Nai-Ying Zheng, et al.
Journal of Clinical and Translational Science|July 3, 2023
Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation NetworkKaren Lane, Marisha E Palm, Eve Marion, et al.
Journal of Clinical and Translational Science|September 1, 2023
Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learnedDaniel F Hanley, Gordon R Bernard, Consuelo H Wilkins, et al.
Science (New York, N.Y.)|October 7, 2016
Posttranslational mutagenesis: A chemical strategy for exploring protein side-chain diversityTom H Wright, Ben J Bower, Justin M Chalker, et al.
Research Involvement and Engagement|April 28, 2023
Key issues for stakeholder engagement in the development of health and healthcare guidelinesJennifer Petkovic, Olivia Magwood, Lyubov Lytvyn, et al.
Cell Host & Microbe|February 24, 2019
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly IndividualsCarole Henry, Nai-Ying Zheng, Min Huang, et al.
Immunity|October 23, 2020
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza VirusesJenna J Guthmiller, Linda Yu-Ling Lan, Monica L Fernández-Quintero, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Journal of Clinical and Translational Science|January 17, 2024
The Trial Innovation Network Liaison Team: building a national clinical and translational community of practiceMarisha E Palm, Dixie D Thompson, Terri Edwards, et al.
Science Translational Medicine|December 10, 2020
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humansHaley L Dugan, Jenna J Guthmiller, Philip Arevalo, et al.
Journal of Clinical and Translational Science|January 17, 2024
Development, implementation, and dissemination of operational innovations across the trial innovation networkMarisha E Palm, Terri L Edwards, Cortney Wieber, et al.
Cell|April 7, 2018
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive AntibodiesYao-Qing Chen, Teddy John Wohlbold, Nai-Ying Zheng, et al.
Journal of Clinical and Translational Science|July 3, 2023
Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation NetworkKaren Lane, Marisha E Palm, Eve Marion, et al.
Journal of Clinical and Translational Science|September 1, 2023
Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learnedDaniel F Hanley, Gordon R Bernard, Consuelo H Wilkins, et al.
Science (New York, N.Y.)|October 7, 2016
Posttranslational mutagenesis: A chemical strategy for exploring protein side-chain diversityTom H Wright, Ben J Bower, Justin M Chalker, et al.
Research Involvement and Engagement|April 28, 2023
Key issues for stakeholder engagement in the development of health and healthcare guidelinesJennifer Petkovic, Olivia Magwood, Lyubov Lytvyn, et al.
Cell Host & Microbe|February 24, 2019
Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly IndividualsCarole Henry, Nai-Ying Zheng, Min Huang, et al.
Immunity|October 23, 2020
Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza VirusesJenna J Guthmiller, Linda Yu-Ling Lan, Monica L Fernández-Quintero, et al.
Pageof 12